Literature DB >> 1875349

Highly selective adenosine A2 receptor agonists in a series of N-alkylated 2-aminoadenosines.

J E Francis1, R L Webb, G R Ghai, A J Hutchison, M A Moskal, R deJesus, R Yokoyama, S L Rovinski, N Contardo, R Dotson.   

Abstract

A wide variety of 2-substituted aminoadenosines were prepared for comparison with the moderately A2 receptor selective adenosine agonist 2-anilinoadenosine (CV-1808). High selectivity combined with significant affinity at the A2 receptor in rat membranes was observed for those amines bearing a two-carbon chain to which was attached an aryl, heteroaryl, or alicyclic moiety. 2-(2-Phenethylamino)adenosine (3d), a 14-fold A2 selective compound, was modified by introduction of a variety of substituents in the benzene ring and the side chain. Some of these changes led to improved A2 affinity and increased selectivity. Replacement of the phenyl moiety by cyclohexenyl produced a 210-fold selective agonist 3ag (CGS 22989) whereas the cyclohexanyl analogue 3af (CGS 22492) was 530-fold selective at the A2 site. These compounds showed hypotensive activity in rat models over a range of doses without the bradycardia observed with less selective agonists.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875349     DOI: 10.1021/jm00112a035

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

Review 1.  Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology.

Authors:  S Jamal Mustafa; R Ray Morrison; Bunyen Teng; Amir Pelleg
Journal:  Handb Exp Pharmacol       Date:  2009

2.  Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor.

Authors:  A P IJzerman; E M van der Wenden; P J van Galen; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-06-15       Impact factor: 4.432

3.  A binding site model and structure-activity relationships for the rat A3 adenosine receptor.

Authors:  P J van Galen; A H van Bergen; C Gallo-Rodriguez; N Melman; M E Olah; A P IJzerman; G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1994-06       Impact factor: 4.436

4.  Covalent binding of a selective agonist irreversibly activates guinea pig coronary artery A2 adenosine receptors.

Authors:  K Niiya; K A Jacobson; S K Silvia; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

Review 5.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

Review 6.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

7.  Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.

Authors:  S M Siddiqi; K A Jacobson; J L Esker; M E Olah; X D Ji; N Melman; K N Tiwari; J A Secrist; S W Schneller; G Cristalli
Journal:  J Med Chem       Date:  1995-03-31       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.